Legal & General Group’s Alder Biopharmaceuticals, Inc. ALDR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-50,360
| Closed | -$949K | – | 3412 |
|
|
2019
Q3 | $949K | Buy |
50,360
+22,539
| +81% | +$425K | ﹤0.01% | 2005 |
|
|
2019
Q2 | $327K | Buy |
27,821
+2,979
| +12% | +$35K | ﹤0.01% | 2227 |
|
|
2019
Q1 | $339K | Hold |
24,842
| – | – | ﹤0.01% | 2227 |
|
|
2018
Q4 | $254K | Buy |
24,842
+1,698
| +7% | +$17.4K | ﹤0.01% | 2254 |
|
|
2018
Q3 | $385K | Hold |
23,144
| – | – | ﹤0.01% | 2195 |
|
|
2018
Q2 | $366K | Sell |
23,144
-2,403
| -9% | -$38K | ﹤0.01% | 2175 |
|
|
2018
Q1 | $324K | Buy |
25,547
+6,060
| +31% | +$76.9K | ﹤0.01% | 2212 |
|
|
2017
Q4 | $223K | Buy |
19,487
+476
| +3% | +$5.45K | ﹤0.01% | 2283 |
|
|
2017
Q3 | $231K | Buy |
19,011
+3,515
| +23% | +$42.7K | ﹤0.01% | 2295 |
|
|
2017
Q2 | $177K | Buy |
15,496
+400
| +3% | +$4.57K | ﹤0.01% | 2348 |
|
|
2017
Q1 | $316K | Sell |
15,096
-193
| -1% | -$4.04K | ﹤0.01% | 2138 |
|
|
2016
Q4 | $318K | Buy |
15,289
+5,202
| +52% | +$108K | ﹤0.01% | 2097 |
|
|
2016
Q3 | $322K | Sell |
10,087
-1,084
| -10% | -$34.6K | ﹤0.01% | 1899 |
|
|
2016
Q2 | $274K | Buy |
11,171
+2,822
| +34% | +$69.2K | ﹤0.01% | 1647 |
|
|
2016
Q1 | $203K | Buy |
8,349
+3,053
| +58% | +$74.2K | ﹤0.01% | 1732 |
|
|
2015
Q4 | $177K | Buy |
5,296
+740
| +16% | +$24.7K | ﹤0.01% | 1792 |
|
|
2015
Q3 | $141K | Buy |
4,556
+1,160
| +34% | +$35.9K | ﹤0.01% | 1864 |
|
|
2015
Q2 | $166K | Buy |
3,396
+2,316
| +214% | +$113K | ﹤0.01% | 1827 |
|
|
2015
Q1 | $32K | Buy |
+1,080
| New | +$32K | ﹤0.01% | 2654 |
|